Other Non-Current Liabilities
Boston Scientific Other Non-Current Liabilities increased by 2.7% to $2.47B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.9%, from $1.95B to $2.47B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a 0.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.19B | $2.30B | $2.22B | $2.00B | $1.99B | $1.92B | $2.04B | $2.00B | $1.93B | $1.86B | $1.97B | $1.92B | $1.80B | $1.84B | $1.87B | $1.95B | $2.38B | $2.39B | $2.41B | $2.47B |
| QoQ Change | — | +4.8% | -3.3% | -9.9% | -0.6% | -3.6% | +6.2% | -2.0% | -3.5% | -3.5% | +5.9% | -2.4% | -6.2% | +2.3% | +1.6% | +4.1% | +22.5% | +0.3% | +0.6% | +2.7% |
| YoY Change | — | — | — | — | -9.2% | -16.6% | -8.3% | -0.3% | -3.1% | -3.0% | -3.3% | -3.8% | -6.5% | -0.9% | -4.9% | +1.4% | +32.4% | +29.8% | +28.6% | +26.9% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Boston Scientific's other non-current liabilities?
- Boston Scientific (BSX) reported other non-current liabilities of $2.47B in Q1 2026.
- How has Boston Scientific's other non-current liabilities changed year-over-year?
- Boston Scientific's other non-current liabilities increased by 26.9% year-over-year, from $1.95B to $2.47B.
- What is the long-term trend for Boston Scientific's other non-current liabilities?
- Over 5 years (2020 to 2025), Boston Scientific's other non-current liabilities has grown at a 0.8% compound annual growth rate (CAGR), from $2.31B to $2.41B.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.